New Systemic Therapies for the Treatment of Advanced Non-Melanoma Skin Cancers: Which of Your Patients May Benefit?
Event
Med Learning Group Summit Meeting, Miami Florida
Overview
On completing this program, attendees should be able to:
Justify the use of new systemic therapies with different mechanisms of action for the treatment of patients with advanced NMSCs failing or not amenable to surgery or radiation
Recommend approaches to identify and mitigate side effects associated with the mechanisms of action of new systemic therapies for the treatment of patients with advanced NMSCs
Incorporate risk stratification into routine clinical practice in order to identify patients who may benefit from new systemic therapies for the treatment of advanced NMSCs
Design management plans in conjunction with interdisciplinary care-based teams for patients with advanced NMSCs not amenable to surgery or radiation